Provided by Tiger Trade Technology Pte. Ltd.

Agenus

7.85
+0.63008.73%
Post-market: 7.81-0.0444-0.57%19:35 EDT
Volume:2.08M
Turnover:16.06M
Market Cap:353.41M
PE:3.14
High:7.88
Open:7.48
Low:7.33
Close:7.22
52wk High:8.85
52wk Low:2.71
Shares:45.02M
Float Shares:40.38M
Volume Ratio:2.76
T/O Rate:5.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.50
EPS(LYR):-0.0034
ROE:-1278.83%
ROA:12.53%
PB:-1.78
PE(LYR):-2,311.54

Loading ...

Agenus Announces Three Bot+bal Presentations Spanning Neoadjuvant and Late-line Colorectal Cancer and Advanced Sarcomas at Esmo 2026

THOMSON REUTERS
·
Jul 17

Agenus (AGEN) Could Be 83% Undervalued On Phase 1b Data And $340 Million Raise

Simply Wall St.
·
Jul 15

Stock Market Today: Dow Jones Futures Fall, Nasdaq 100 Gains as Trump Calls US the 'Guardian' of Hormuz Strait—Tower Semiconductor, Twin Vee, JPMorgan In Focus

Benzinga Earnings
·
Jul 14

Why Is Agenus (AGEN) Stock Up Today?

TIPRANKS
·
Jul 14

Agenus is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 14

Agenus price target raised to $30 from $23 at H.C. Wainwright

TIPRANKS
·
Jul 14

Agenus announces strategic prioritization of neoadjuvant BOT+BAL

TIPRANKS
·
Jul 14

Agenus Secures Strategic Financing to Advance Colon Cancer Program

TIPRANKS
·
Jul 13

U.S. Stocks on the Move-american Express, Deckers, Q32 Bio

Reuters
·
Jul 13

Agenus Signs Deal to Sell Up to $340 Million Worth of Securities; Shares Up Pre-Bell

MT Newswires Live
·
Jul 13

Agenus Secures up to $340 Mln to Advance Colon Cancer Drug into Late-stage Study; Shares Jump

Reuters
·
Jul 13

Agenus Issues Series A, Series B Warrants in USD 85 Million Private Placement

Reuters
·
Jul 13

Agenus - to Increase Board to Nine, Adding Two Directors Designated by Commodore Capital Master Lp

THOMSON REUTERS
·
Jul 13

Agenus Announces Oversubscribed Private Placement of up to $340 Million to Advance Registrational Robbin Trial of Neoadjuvant Bot+bal in Mss Colon Cancer

THOMSON REUTERS
·
Jul 13

Agenus - Discontinues Financial Support for Battman Phase 3 Study

THOMSON REUTERS
·
Jul 13

Agenus Issues 56,525 New Warrants, Sets SEC Resale Registration Deadline Within 90 Days

Reuters
·
Jul 07

Agenus' Potential Colorectal Cancer Combination Shows 21.2-Month Survival

MT Newswires Live
·
Jul 06

Agenus Reports Landmark Bot+bal Data Showing 33% Three-year Overall Survival in Refractory Mss Metastatic Colorectal Cancer Without Active Liver Metastases at Esmo Gi 2026

THOMSON REUTERS
·
Jul 06

Agenus to Present Three-year Survival Data from Bot+bal Phase 1b Study in MSS Metastatic Colorectal Cancer at ESMO GI 2026

Reuters
·
Jun 25

Agenus Shareholders Approve Governance, Compensation and Auditors

TIPRANKS
·
Jun 23